West Pharmaceutical Services (WST) said Thursday that Chief Financial Officer Bernard Birkett plans to retire later this year and that a search for his successor is underway.
Birkett is expected to remain in the CFO role until a successor is appointed and will then serve as an advisor to support a smooth transition, the company said.
West also said it appointed Shane Campbell as chief proprietary segment officer, starting May 5. Campbell most recently served as chief commercial officer of the construction materials business at Carlisle (CSL).
Shares of West Pharmaceutical Services were down 3.5% in recent trading.
Price: 210.50, Change: -7.68, Percent Change: -3.52
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。